Effect of the iron-lactoferrin complex on women with primary dysmenorrhea
- Conditions
- Primary dysmenorrhea
- Registration Number
- JPRN-UMIN000013220
- Lead Sponsor
- Soiken Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 25
Not provided
1) Subject having medical treatment in a hospital or clinic 2) Subject having treatment or previous history for serious cardiovascular, respiratory, endocrine, or metabolic disorders 3) Subject having any infectious diseases or their possibility 4) Subject who ended participation in another clinical trial less than 3 months before 5) Subject having cedar or cypress pollen allergy 6) Subject having a food allergy, specially dairy products 7) For female subjects: pregnancy or possibility of pregnancy, or intending to become pregnant during the study. 8) Subject who has had a blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months of the start of the present study 9) Subject deemed unsuitable by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is a combination of subjective measurements (Moos menstrual distress questionnaire, Visual rating scale, and Verbal rating scale) and an objective measurement (Finger-tip accelerated plethysmography) during a menstruating period.
- Secondary Outcome Measures
Name Time Method